Owner BRISTOL-MYERS SQUIBB PHARMA COMPANY

Inventors Jacobson, Irina, C.; Qiao, Jennifer; Smallheer, Joanne, M.; Nakajima, Suanne; Wexler, Ruth, R.; Wang, Shuaige; Quan, Mimi, L

Agent Callinan

Pub. Number AU-A-2001297862

PCT Number PCT/US01/51621

PCT Pub. Number WO2002/102380

Priority 60/246,107 06.11.00 US; 60/313,552 20.08.01 US

Filing date 30 October 2001

Wipo publication date 2 January 2003

A61K 031/445 - Non-condensed piperidines, e.g. piperocaine

A61K 031/4704 - 2-Quinolinones, e.g. carbostyril

C07D 211/76 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

C07D 401/14 Heterocyclic compounds containing two or more hetero rings

C07D 409/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 241/08 Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 215/22 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 223/12 Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom

A61P 007/02 Drugs for disorders of the blood or the extracellular fluid

A61K 031/495 - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine